Old Web
English
Sign In
Acemap
>
Paper
>
103P First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
103P First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
2021
Z. Andrić
Gabriella Gálffy
M. Cobo Dols
B. Szima
G. Stojanovic
M. D. Petrović
E. Felip Font
D. Vicente-Baz
S. Ponce Aix
O. Juan-Vidal
S. Tehenes
Zsuzsanna Szalai
György Losonczy
A. Calles Blanco
R. Bernabé
K. Duecker
D. Zhou
A. Schroeder
G. Guezel
Fortunato Ciardiello
Keywords:
Oncology
Internal medicine
Squamous non-small cell lung cancer
Chemotherapy
Avelumab
Cetuximab
in patient
first line
Medicine
Correction
Source
Cite
Save
0
References
1
Citations
NaN
KQI
[]
map